Clinical Trial Detail

NCT ID NCT03095248
Title Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

neurilemmoma

malignant ependymoma

acoustic neuroma

malignant glioma

meningioma

Therapies

Selumetinib

Age Groups: child adult

No variant requirements are available.